EU5 Neurovascular Embolization Procedures Outlook to 2025

2018-12-01
EU5 Neurovascular Embolization Procedures Outlook to 2025 Summary GlobalData’s new report, EU5 Neurovascular Embolization Procedures Outlook to 2025, provides key procedures data on the EU5 Neurovascular Embolization Procedures. The report...

South Korea Neurology Procedures Outlook to 2025 – Hydrocephalus Shunting Procedures, Neurovascular Thrombectomy Procedures, ICP Procedures and Others

2018-12-01
South Korea Neurology Procedures Outlook to 2025 – Hydrocephalus Shunting Procedures, Neurovascular Thrombectomy Procedures, ICP Procedures and Others Summary GlobalData’s new report, South Korea Neurology Procedures Outlook to 2025,...

Asia-Pacific Neurovascular Accessory Procedures Outlook to 2025

2018-12-01
Asia-Pacific Neurovascular Accessory Procedures Outlook to 2025 Summary GlobalData’s new report, Asia-Pacific Neurovascular Accessory Procedures Outlook to 2025, provides key procedures data on the Asia-Pacific Neurovascular Accessory...

Competitor Landscape: Spondyloarthritis

2018-11-30
Competitor Landscape: Spondyloarthritis Summary Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the spondyloarthritis (SpA) market, analysis of current & potential future...

Multiple Sclerosis: Dynamic Market Forecast to 2026

2018-11-30
Multiple Sclerosis: Dynamic Market Forecast to 2026 Summary Multiple Sclerosis (MS) is a rapidly evolving field in which new developments are constantly influencing the market landscape. The Dynamic Market Forecast is designed to help clients...

Competitor Landscape: Non-alcoholic Steatohepatitis (NASH)

2018-11-30
Competitor Landscape: Non-alcoholic Steatohepatitis (NASH) Summary Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the NASH market, analysis of current & potential future...

Competitor Landscape: Graft Versus Host Disease (GVHD)

2018-11-30
Competitor Landscape: Graft Versus Host Disease (GVHD) Summary Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the graft versus host disease (GVHD) market, analysis of current...

Competitor Landscape: Systemic Sclerosis (Scleroderma)

2018-11-30
Competitor Landscape: Systemic Sclerosis (Scleroderma) Summary Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Systemic Sclerosis (Scleroderma) market, analysis of current...

Atopic Dermatitis: Epidemiology Forecast to 2027

2018-11-27
Atopic Dermatitis: Epidemiology Forecast to 2027 Summary Atopic dermatitis (AD) or atopic eczema is a chronic inflammatory skin disease characterized by itchy skin lesions and rashes. Although the condition affects people of all ages, it is...

Malaria: Epidemiology Forecast to 2027

2018-11-27
Malaria: Epidemiology Forecast to 2027 Summary Malaria is a vector-borne disease caused by parasites of the genus Plasmodium. Malaria is transmitted through the bite of the female Anopheles mosquito. Upon infecting a new human host, parasites...
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy